Homburger advised ADC Therapeutics SA on the placement. ADC Therapeutics SA (NYSE:ADCT), a commercial-stage biotechnology company headquartered in Switzerland, completed the offering of 13.4 m common...
You must be a Standard 1 Year member to access this content.
Davis Polk and Homburger advised ADC Therapeutics, while Cooley and Lenz & Staehelin advised the underwriter. ADC Therapeutics SA announced a registered secondary offering of 12,000,000...
You must be a Standard 1 Year member to access this content.
Homburger and Davis Polk & Wardwell advised ADC Therapeutics on the deal. DC Therapeutics SA (NYSE:ADCT), a commercial-stage biotechnology company headquartered in Switzerland, announced that it...
You must be a Standard 1 Year member to access this content.
Homburger advised ADC Therapeutics SA on the agreement. ADC Therapeutics SA (NYSE: ADCT), a Swiss-based commercial-stage oncology-focused biotechnology company, announced that it had entered into a...
You must be a Standard 1 Year member to access this content.
